Badaro No.19 Ship Investment Co
KRX:155900
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Badaro No.19 Ship Investment Co
KRX:155900
|
KR |
|
N
|
Novoprotein Scientific Inc
SSE:688137
|
CN |
|
Wing On Company International Ltd
HKEX:289
|
HK |
Balance Sheet
Balance Sheet Decomposition
Badaro No.19 Ship Investment Co
Badaro No.19 Ship Investment Co
Balance Sheet
Badaro No.19 Ship Investment Co
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2 892
|
2 796
|
2 624
|
2 071
|
3 131
|
2 425
|
2 097
|
1 959
|
7 553
|
12 377
|
|
| Cash Equivalents |
2 892
|
2 796
|
2 624
|
2 071
|
3 131
|
2 425
|
2 097
|
1 959
|
7 553
|
12 377
|
|
| Short-Term Investments |
0
|
317
|
338
|
1 034
|
439
|
693
|
718
|
1 875
|
1 935
|
1 986
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
2
|
7
|
6
|
3
|
6
|
|
| Other Current Assets |
121
|
384
|
312
|
0
|
322
|
151
|
21
|
498
|
22
|
24
|
|
| Total Current Assets |
3 013
|
3 497
|
3 274
|
3 106
|
3 893
|
3 272
|
2 843
|
4 337
|
9 512
|
14 393
|
|
| PP&E Net |
55 562
|
55 033
|
39 076
|
49 403
|
43 512
|
44 558
|
43 237
|
35 701
|
37 913
|
37 429
|
|
| PP&E Gross |
55 562
|
55 033
|
39 076
|
49 403
|
43 512
|
44 558
|
43 237
|
35 701
|
37 913
|
37 429
|
|
| Accumulated Depreciation |
1 250
|
4 142
|
24 019
|
15 657
|
14 167
|
15 635
|
19 094
|
22 871
|
25 908
|
30 797
|
|
| Other Long-Term Assets |
1 445
|
622
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
60 021
N/A
|
59 153
-1%
|
42 350
-28%
|
52 509
+24%
|
47 405
-10%
|
47 831
+1%
|
46 080
-4%
|
40 039
-13%
|
47 425
+18%
|
51 821
+9%
|
|
| Liabilities | |||||||||||
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1 004
|
1 101
|
734
|
1 620
|
2 054
|
1 809
|
1 324
|
1 045
|
867
|
2 781
|
|
| Total Current Liabilities |
1 004
|
1 101
|
734
|
1 620
|
2 054
|
1 809
|
1 324
|
1 045
|
867
|
2 781
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
3 282
|
0
|
486
|
165
|
165
|
420
|
1 900
|
1 869
|
|
| Total Liabilities |
1 004
N/A
|
1 101
+10%
|
4 016
+265%
|
1 620
-60%
|
2 540
+57%
|
1 973
-22%
|
1 489
-25%
|
1 465
-2%
|
2 767
+89%
|
4 650
+68%
|
|
| Equity | |||||||||||
| Common Stock |
76 000
|
76 000
|
76 000
|
76 000
|
76 000
|
76 000
|
76 000
|
76 000
|
76 000
|
76 000
|
|
| Retained Earnings |
15 754
|
17 612
|
36 044
|
22 415
|
32 279
|
30 217
|
30 088
|
38 131
|
29 059
|
23 068
|
|
| Additional Paid In Capital |
139
|
139
|
139
|
139
|
139
|
139
|
139
|
139
|
139
|
139
|
|
| Unrealized Security Profit/Loss |
2 317
|
793
|
497
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
949
|
318
|
1 264
|
2 835
|
1 005
|
64
|
1 459
|
566
|
2 421
|
5 900
|
|
| Total Equity |
59 017
N/A
|
58 052
-2%
|
38 333
-34%
|
50 889
+33%
|
44 865
-12%
|
45 857
+2%
|
44 591
-3%
|
38 574
-13%
|
44 658
+16%
|
47 171
+6%
|
|
| Total Liabilities & Equity |
60 021
N/A
|
59 153
-1%
|
42 350
-28%
|
52 509
+24%
|
47 405
-10%
|
47 831
+1%
|
46 080
-4%
|
40 039
-13%
|
47 425
+18%
|
51 821
+9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
|